Brief: FDA Clears For Marketing Dexcom's Stelo Glucose Biosensor System For Children
12/06/2026 20:45
BRIEF-FDA Clears For Marketing Dexcom's Stelo Glucose Biosensor System For Children June 12 (Reuters) - FDA:
FDA CLEARS FIRST OVER--COUNTER CONTINUOUS GLUCOSE MONITOR FOR CHILDREN
FDA: CLEARED FOR MARKETING FIRST OTC CONTINUOUS GLUCOSE MONITOR FOR CHILDREN, DEXCOM’S STELO GLUCOSE BIOSENSOR SYSTEM - WEBSITE
Further company coverage: DXCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DexCom
See all newsU.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
FDA clears first over-the-counter glucose monitor for children
Brief: FDA Clears For Marketing Dexcom's Stelo Glucose Biosensor System For Children
Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction
U.S. RESEARCH ROUNDUP- Apple, Lennar, Toll Brothers